Investors making a wish list of stocks to watch should take a look at Exact Sciences Corporation (NASDAQ:EXAS). The stock is offering a price-to-sales ratio of 26.7. This situation may create an opportunity where long term players can win with either market bounce, or when long-term value is realized. The broad Medical Laboratories & Research industry has an average P/S ratio of 134.24, which is significantly worse than the sector’s 6.54. In the past 13-year record, this ratio went down as low as 10.55 and as high as 1325.45. Also, it is down from 88% of the total 217 rivals across the globe.
EXAS traded at an unexpectedly high level on 01/18/2018 when the stock experienced a 2.33% gain to a closing price of $48.79. The company saw 4.67 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 2.14 million shares a day, this signifies a pretty significant change over the norm.
Analysts are speculating a 37.32% move, based on the high target price ($67) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $58.78 price target, but the stock is already up 187.85% from its recent lows. However, the stock is trading at -23.29% versus recent highs ($63.60). Analysts believe that we could see stock price minimum in the $41 range (lowest target price), allowing for another -15.97% drop from its current position. Leading up to this report, we have seen a -5.37% fall in the stock price over the last 30 days and a 4.95% increase over the past 3 months. Overall, the share price is down -7.14% so far this year. Additionally, EXAS had a day price range of $47.17 to $50.62.Exact Sciences Corporation (EXAS) Price Potential
Heading into the stock price potential, Exact Sciences Corporation needs to grow just 22.98% to cross its median price target of $60. In order to determine directional movement, the 50-day and 200-day moving averages for Exact Sciences Corporation (NASDAQ:EXAS) are $53.57 and $47.34. Given that liquidity is king in short-term, EXAS is a stock with 119.22 million shares outstanding that normally trades 8.42% of its float. The stock price recently experienced a 5-day loss of -9.58% with 3.04 average true range (ATR). EXAS has a beta of 0.71 and RSI is 40.43.
Investors also need to beware of the Sunrun Inc. (NASDAQ:RUN) valuations. The stock trades on a P/S of 1.29, which suggests that the shares are attractive compared with peers. The broad Semiconductor – Specialized industry has an average P/S ratio of 16.39, which is significantly worse than the sector’s 14.93. In the past 4-year record, this ratio went down as low as 1.12 and as high as 3.82. Also, it is up from 63% of the total 838 rivals across the globe.Sunrun Inc. (RUN)’s Lead Over its Technicals
Sunrun Inc. by far traveled 40.62% versus a 1-year low price of $4.21. The share price was last seen -2.79% lower, reaching at $5.92 on 01/18/2018. At recent session, the prices were hovering between $5.775 and $6.13. This company shares are 73.82% off its target price of $10.29 and the current market capitalization stands at $637.41M. The recent change has given its price a -0.04% deficit over SMA 50 and -23.91% deficit over its 52-week high. The stock witnessed -2.31% declines, 6.86% gains and -18.57% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found RUN’s volatility during a week at 4.7% and during a month it has been found around 3.02%.
Sunrun Inc. (RUN) exchanged hands at an unexpectedly high level of 1.93 million shares over the course of the day. Noting its average daily volume at 0.94 million shares each day over the month, this signifies a pretty significant change over the norm.Sunrun Inc. Target Levels
The market experts are predicting a 68.92% rally, based on the high target price ($10) for Sunrun Inc. shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $8 range (lowest target price). If faced, it would be a 35.14% jump from its current position. Overall, the share price is up 0.34% year to date.